| Swedish Orphan Biovitrum AG - Elocta 500 I.E., Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
| 65843 | | 02 | | Elocta 500 I.E. | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | B02BD02 | | Coagulation Factor Viii | | 23.06.2016 | | |
|
| Composition |
| Praeparatio cryodesiccata: efmoroctocogum alfa 500 U.I., histidinum, natrii chloridum, calcii chloridum dihydricum, saccharum, polysorbatum 20, acidum hydrochloridum aut natrii hydroxidum pro vitro corresp. natrium 14.1 mg.
Solvens: aqua ad iniectabile. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Lyophilisate and solvent | | | | | | | | Active Agent | Dose |
|---|
| Efmoroctocogum Alfa | 500 UI |
| | BAG: Active Agent | Dose |
|---|
| Efmoroctocogum Alfa | 500 UI |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum aut Natrii Hydroxidum | | Calcii Chloridum Dihydricum | | Histidine | | Sodium Chloride | | Polysorbatum 20 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | Set(s) | 372.60 | 423.35 | B | SL | No |
|
